Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms
- 1 April 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (7) , 1486-1497
Abstract
Invasive lobular carcinoma (ILC) accounts for 8%–14% of all breast cancer cases. The main hallmark of ILCs is the functional loss of the cell–cell adhesion protein E-cadherin. Nonetheless, loss of E-cadherin alone does not predispose mice to mammary tumor development, indicating that additional perturbations are required for ILC formation. Previously, we identified an N-terminal truncation variant of ASPP2 (t-ASPP2) as a driver of ILC in mice with mammary-specific loss of E-cadherin. Here we showed that expression of t-ASPP2 induced actomyosin relaxation, enabling adhesion and survival of E-cadherin–deficient murine mammary epithelial cells on stiff matrices like fibrillar collagen. The induction of actomyosin relaxation by t-ASPP2 was dependent on its interaction with protein phosphatase 1, but not on t-ASPP2–induced YAP activation. Truncated ASPP2 collaborated with both E-cadherin loss and PI3K pathway activation via PTEN loss in ILC development. t-ASPP2–induced actomyosin relaxation was required for ILC initiation, but not progression. Conversely, YAP activation induced by t-ASPP2 contributed to tumor growth and progression while being dispensable for tumor initiation. Together, these findings highlight two distinct mechanisms through which t-ASPP2 promotes ILC initiation and progression. Significance: Truncated ASPP2 cooperates with E-cadherin and PTEN loss to drive breast cancer initiation and progression via two distinct mechanisms. ASPP2-induced actomyosin relaxation drives tumor initiation, while ASPP2-mediated YAP activation enhances tumor progression.Keywords
All Related Versions
Funding Information
- Dutch Cancer Society (2015-7589)
- ERC (319661)
- NWO (VENI 016156012)
- NWO (VICI 91814643)
This publication has 51 references indexed in Scilit:
- Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancerCellular Oncology, 2013
- ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cellsCell Death & Differentiation, 2013
- Rho protein crosstalk: another social network?Trends in Cell Biology, 2011
- Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceDisease Models & Mechanisms, 2011
- PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZJournal of Biological Chemistry, 2011
- Non-muscle myosin II takes centre stage in cell adhesion and migrationNature Reviews Molecular Cell Biology, 2009
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJournal of Clinical Investigation, 2009
- Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2Proceedings of the National Academy of Sciences, 2008
- Myosin phosphatase target subunit: Many roles in cell functionBiochemical and Biophysical Research Communications, 2008
- ASPP: a new family of oncogenes and tumour suppressor genesBritish Journal of Cancer, 2007